Indoor Radon Exposure and COPD, Synergic Association? A Multicentric, Hospital-Based Case-Control Study in a Radon-Prone Area.


Journal

Archivos de bronconeumologia
ISSN: 1579-2129
Titre abrégé: Arch Bronconeumol
Pays: Spain
ID NLM: 0354720

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 01 10 2020
accepted: 23 11 2020
entrez: 14 6 2022
pubmed: 15 6 2022
medline: 16 6 2022
Statut: ppublish

Résumé

COPD is a multifactorial disease which causes considerable mortality and morbidity worldwide. Previous studies assessing the possible relationship between indoor radon exposure and COPD have shown inconclusive results. A multicentric, hospital-based, case-control study was conducted in a Spanish radon-prone area. COPD cases were confirmed by spirometry and controls were selected due to trivial surgery or procedures not related to tobacco consumption. All participants had to have lived for at least 15 years in the same dwelling. Radon measurements were conducted individually in dwellings using alpha-track detectors. Results were obtained using multivariate logistic regression. 189 cases and 747 controls took part. There was no significant association between residential radon concentrations and COPD onset with a OR of 1.12 (95%CI 0.41-3.06) for individuals exposed to more than 200Bq/m No association between indoor radon and COPD has been observed. However, there might be some effect modification on the COPD risk in heavy smokers when high radon exposure is present. This is supported by the additive synergy observed. Also, a possible association between indoor radon and COPD onset in never and light smokers needs to be further studied.

Sections du résumé

BACKGROUND BACKGROUND
COPD is a multifactorial disease which causes considerable mortality and morbidity worldwide. Previous studies assessing the possible relationship between indoor radon exposure and COPD have shown inconclusive results.
METHODS METHODS
A multicentric, hospital-based, case-control study was conducted in a Spanish radon-prone area. COPD cases were confirmed by spirometry and controls were selected due to trivial surgery or procedures not related to tobacco consumption. All participants had to have lived for at least 15 years in the same dwelling. Radon measurements were conducted individually in dwellings using alpha-track detectors. Results were obtained using multivariate logistic regression.
RESULTS RESULTS
189 cases and 747 controls took part. There was no significant association between residential radon concentrations and COPD onset with a OR of 1.12 (95%CI 0.41-3.06) for individuals exposed to more than 200Bq/m
CONCLUSIONS CONCLUSIONS
No association between indoor radon and COPD has been observed. However, there might be some effect modification on the COPD risk in heavy smokers when high radon exposure is present. This is supported by the additive synergy observed. Also, a possible association between indoor radon and COPD onset in never and light smokers needs to be further studied.

Identifiants

pubmed: 35699045
pii: S1579-2129(21)00321-9
doi: 10.1016/j.arbr.2020.11.020
pii:
doi:

Substances chimiques

Radon Q74S4N8N1G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

630-636

Informations de copyright

Copyright © 2020 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Alberto Ruano-Ravina (A)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública - CIBERESP), Spain; Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela - IDIS), Santiago de Compostela, Spain. Electronic address: alberto.ruano@usc.es.

Candela Cameselle-Lago (C)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain.

María Torres-Durán (M)

Service of Neumology, University Hospital Complex of Vigo, Spain.

Ana Pando-Sandoval (A)

Service of Neumology, Central University Hospital of Asturias, Spain.

Raquel Dacal-Quintas (R)

Service of Neumology, University Hospital Complex of Ourense, Spain.

Luis Valdés-Cuadrado (L)

Service of Neumology, Clinic University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.

Jesús Hernández-Hernández (J)

Service of Neumology, Ávila Hospital Complex, Ávila, Spain.

Angélica Consuegra-Vanegas (A)

Service of Neumology, A Coruña University Hospital, A Coruña, Spain.

José Andrés Tenes-Mayén (JA)

Service of Neumology, Ávila Hospital Complex, Ávila, Spain.

Leonor Varela-Lema (L)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública - CIBERESP), Spain.

Alberto Fernández-Villar (A)

Service of Neumology, University Hospital Complex of Vigo, Spain.

Juan Miguel Barros-Dios (JM)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública - CIBERESP), Spain; Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela - IDIS), Santiago de Compostela, Spain.

Mónica Pérez-Ríos (M)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública - CIBERESP), Spain; Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela - IDIS), Santiago de Compostela, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH